微流控芯片药物诱导细胞凋亡

发展了一种以微流控芯片为平台的药物诱导细胞凋亡的新方法.选择HeLa细胞为对象,通过浓度梯度芯片形成稳定的药物浓度梯度,诱导HeLa细胞凋亡,利用荧光能量共振转移（fluorescence resonance energy transfer,FRET）成像系统进行实时监测,分析细胞对不同浓度化合物的毒性反应.结果表明,细胞在顺铂诱导下发生明显的起泡和皱缩,FRET比率值逐渐降低,在药物浓度梯度作用下,芯片每个通道内细胞呈现不同程度的凋亡.该方法实现了药物浓度梯度诱导细胞凋亡的实时监测和定量分析,为抗肿瘤药物评价和高通量药物筛选提供了新的手段.     

快速线扫描拉曼成像技术在研究CaSki细胞凋亡过程中的应用

应用快速线扫描拉曼成像技术研究了在抗肿瘤药物顺铂诱导下宫颈癌Ca Ski细胞凋亡过程中细胞色素c、蛋白质和脂质等的时空变化规律.结果表明,细胞色素c与蛋白质的相对拉曼峰强可以反映细胞凋亡程度.与常用的表征细胞活性的噻唑蓝(MTT)实验的统计方法相比,利用拉曼成像技术可以更灵敏地观察到细胞凋亡早期生物活性分子的变化,从而在单细胞水平检测细胞凋亡过程,为解析药物与细胞的作用机制提供分子水平信息.     

金属配合物作为蛋白酶体抑制剂的研究进展

蛋白酶体涉及机体的多种生理功能和许多疾病的发病机制.近年来的研究发现,金属配合物尤其是铜的配合物对肿瘤细胞中蛋白酶体活性有较强的抑制作用并能诱导肿瘤细胞凋亡.本文综述了金属配合物作为蛋白酶体抑制剂及肿瘤细胞凋亡诱导剂的研究进展.     

硒化壳聚糖诱导NB4细胞凋亡及周期阻断作用

为研究硒化壳聚糖对NB4细胞的凋亡及周期阻断作用,用流式细胞法观察了药物对细胞的诱导凋亡及周期阻断作用。结果表明,硒化壳聚糖作用NB4细胞24 h,可剂量依赖性地诱导细胞凋亡并使G0—G1期细胞增多。提示硒化壳聚糖可诱导细胞凋亡,并对NB4细胞周期有特异性阻断作用。     

聚乙烯亚胺介导siRNA和顺铂协同抗肿瘤治疗

用聚乙烯亚胺(PEI)为载体,介导siRNA(siSurvivin)沉默肿瘤细胞抗凋亡基因survivin,并与抗癌药物(顺铂)进行协同抗肿瘤治疗.凝胶阻滞电泳实验显示,PEI能够对siRNA进行有效复合,在PEI/siRNA质量比为0.4时实现完全阻滞.细胞耐药性实验证明了耐顺铂细胞(A549DDP细胞)的survivin基因过度表达且耐顺铂能力是顺铂敏感细胞(A549细胞)的8倍.RT-PCR实验验证了PEI担载siSurvivin后对survivin基因实现了有效沉默,与顺铂药物共同作用后不影响基因沉默效果.细胞凋亡实验验证了基因与药物协同作用后细胞的凋亡率达到60.9％,而单独药物或PEI/siSurvivin复合物分别作用后的细胞凋亡率仅分别为30.2％和19.8％.细胞增殖实验进一步验证了PEI介导siSurvivin与顺铂联合治疗能够实现有效地协同抗肿瘤效果.     

共固定化TNF-α/IFN-γ对宫颈癌HeLa细胞的长效抑制作用

利用光化学固定方法,将TNF-α/IFN-γ共同固定在组织培养聚苯乙烯培养孔内,选择最佳固定细胞因子剂量20ng/well,对HeLa细胞行长效性实验研究.培养时间为1d、2d、3d、4d、5d和6d.同时设游离TNF-α+IFN-γ与纯无血清培养对照组.计算TNF-α/IFN-γ共固定药物对HeLa细胞抑制率.并采用荧光显微镜及流式细胞仪行Hoechst 33258染色定性分析和磷脂酰丝氨酸外翻定量分析细胞凋亡.结果表明低剂量20ng/well的共固定细胞因子对HeLa细胞的生长抑制具有时间效应,作用第5d抑制率达到92%,游离细胞因子作用第3d达到最大抑制率76%,第6d抑制率减少到41%.Hoechst 33258细胞形态学研究显示,药物作用6d时,20ng/well共固定细胞因子诱导的凋亡效果比游离细胞因子的更为显著.流式细胞仪磷脂酰丝氨酸外翻定量分析表明作用第6d,20ng/well共固定药物诱导宫颈癌细胞早中期凋亡的比率比同样浓度游离药物凋亡率高14.8%.经光化学固定后低剂量细胞因子TNF-α/IFN-γ具有抑制HeLa细胞生长与诱导HeLa细胞凋亡的活性,并且共固定化细胞因子的抑癌活性和药效持续性比游离细胞因子显著.     

4-芳基-4H-苯并吡喃类衍生物细胞凋亡诱导活性的定量构效关系研究

细胞凋亡是与个体发育、组织更新、免疫调节等生理过程密切相关的细胞生理性死亡过程.在生物体内,细胞的过度凋亡不仅会造成细胞缺失,而且还会引发各种神经退行性和自身免疫性疾病.但是,凋亡不足则会引起体内非正常细胞的存活和积累,导致癌症等多种疾病的发生~([1]).近年来,一系列研究表明4-芳基-4H-苯并吡喃类衍生物对人类乳腺癌细胞具有凋亡诱导活性~([2]),这使得该类小分子成为了治疗乳腺癌的潜在性药物.     

茶多酚锰合成、表征及络合和诱导肿瘤细胞凋亡的研究

合成了茶多酚锰(TP-Mn)和茶多酚锗(TP-Ge), 并采用红外光谱法及液相色谱质谱联用技术表征TP-Mn的理化特性. 选用反向液相色谱(RP-HPLC)和电感藕合等离子体质谱(ICP-MS)技术研究牛血清白蛋白(BSA)络合TP-Mn的能力, 指出BSA可直接络合于TP-Mn. 采用MTT法研究TP和TP-Mn诱导Hela卵巢癌细胞的凋亡率. 结果表明, TP和TP-Mn均能诱导Hela卵巢癌细胞凋亡, 但TP-Mn诱导凋亡率约为TP的2倍. 比较TP-Ge和TP-Mn诱导Raji人B淋巴瘤细胞凋亡率发现, 两者诱导肿瘤细胞的凋亡率几乎相同, 均高达86%左右. 人血清白蛋白(HSB)可作为输送TP-Ge和TP-Mn的药物载体.     

基于DNA纳米花的细胞自噬基因沉默用于增敏抗肿瘤化疗

自噬是真核细胞降解蛋白质的重要途径之一, 在细胞的更新代谢中起重要作用. 肿瘤细胞借助高水平的细胞自噬能够阻断细胞凋亡途径, 降低化疗药物的抗肿瘤效果. 本文通过设计编码有核酸适配体序列(Aptamer)和DNA酶序列(DNAzyme)的多功能DNA纳米花, 利用DNA序列可负载化疗药物阿霉素(Dox)的特性, 实现了对肿瘤细胞特异靶向的药物递送, 并高效沉默肿瘤细胞的自噬相关基因ATG5, 达到增敏抗肿瘤化疗的效果. 通过RT-PCR实验验证合成的DNA纳米花可以有效剪切肿瘤细胞中自噬相关基因ATG5的mRNA; 并通过DNA纳米花的细胞毒性和细胞凋亡实验研究了其对肿瘤细胞系MCF-7的靶向治疗作用, 结果显示该多功能DNA纳米花在增敏抗肿瘤化疗方面具有明显优势.     

10-羟基喜树碱的光谱性质、抗肿瘤活性及应用于细胞标记研究

通过紫外-可见光谱、荧光光谱和红外光谱等方法研究了药物10-羟基喜树碱(HCPT)的光谱性质.采用溴化噻唑蓝四氮唑(MTT)法测定了HCPT对3种肿瘤细胞(HeLa,MCF-7和HT1080)的抗肿瘤活性,其IC50值分别为16.37,16.73和19.24μg/mL.测定了HCPT对正常细胞人胚肾细胞系HEK293T的生长抑制活性,最高抑制率达88.72%,表明正常细胞比3种肿瘤细胞对药物HCPT更敏感.以HeLa细胞为模型,利用Annexin V-FITC细胞凋亡检测试剂盒研究了HCPT的抗肿瘤作用机制,发现几乎所有细胞均同时被Annexin V-FITC和碘化丙啶(PI)染色,细胞膜为绿色,而细胞核为红色,表明HCPT诱导了HeLa细胞的晚期凋亡.通过荧光显微镜观察了HCPT在HeLa细胞中的分布,为其在细胞标记中的应用提供了科学依据.     

Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis

Histone deacetylase inhibitors (HDIs), a new class of anti-cancer agents, have been reported to suppress formation of osteoclast precursors and their fusion into multinucleated cells. However, little is known about the effect of HDIs on mature osteoclasts, which may have significance for their therapeutic use. Here, we demonstrate a novel action of HDIs on osteoclast apoptosis. Primary multinucleated mature osteoclasts were prepared from mouse bone marrow cells. Treatment of osteoclasts with the HDI trichostatin A (TSA) caused apoptosis, as confirmed by annexin V staining and caspase activation. TSA caused the upregulation of p21WAF1 in osteoclasts. To understand the role of p21(WAF1) upregulation in TSA-treated osteoclasts, shRNA against p21(WAF1)-containing lentivirus was introduced into osteoclasts. The suppression of p21(WAF1) decreased TSA-directed osteoclast apoptosis. Collectively, our results provide evidence that TSA causes osteoclast apoptosis, which involves, in part, TSA-induced upregulation of p21(WAF1), and strongly supports HDIs as potential therapeutic agents for excessive bone resorption.     

Apoptosis Evaluation by Electrochemical Techniques

Apoptosis has close relevance to pathology, pharmacology, and toxicology. Accurate and convenient detection of apoptosis would be beneficial for biological study, clinical diagnosis, and drug development. Based on distinct features of apoptotic cells, a diversity of analytical techniques have been exploited for sensitive analysis of apoptosis, such as surface plasmon resonance, electrochemical methods, flow cytometry, and some imaging assays. Among them, the features of simplicity, easy operation, low cost, and high sensitivity make electrochemical techniques powerful tools to investigate electron‐transfer processes of in vitro biological systems. In this contribution, a general overview of current knowledge on various technical approaches for apoptosis evaluation is provided. Furthermore, recently developed electrochemical biosensors for detecting apoptotic cells and their advantages over traditional methods are summarized. One of the main considerations focuses on designing the recognition elements based on various biochemical events during apoptosis.     

A comparison of the diastereoisomers, silybin A and silybin B, on the induction of apoptosis in K562 cells

Two diastereoisomers of silybin, silybin A and silybin B, were separated from silymarin by HPLC in our previous study. The present study assessed the effects of the diastereoisomers on cell apoptosis, and compared these with their mixture, silybin, in human chronic myeloid leukemia K562 cells. Both isomers showed stronger effects on cell growth inhibition and apoptosis induction than silybin. Compared with silybin B, silybin A showed higher effects on the production of intracellular reactive oxygen species and Ca2+. These results suggest that silybin A and silybin B have similar potency on apoptosis induction with different oxidative effects. Antagonistic effects may exist between silybin A and silybin B, partially through ROS production and Ca2+ increase.     

CDK9 inhibitors push cancer cells over the edge

The trouble with CDK active-site inhibitors is their tendency to have off-target effects. This is not surprising, as the ATP binding sites of most protein kinases are very similar. Wang et?al. (2010) have used some clever screening approaches to identify selective CDK9 inhibitors that drive cancer cells into apoptosis.     

Apoptosis induced by NaYF_4:Eu~(3+) nanoparticles in liver cells via mitochondria damage dependent pathway

As lanthanide-doped sodium yttrium flouride(NaYF_4)nanoparticles have great potential inbiomedical applications,their biosafety is important and has attracted significant attention.In the present work,three different sized NaYF_4:Eu~(3+)nanoparticles have been prepared.Liver BRL 3 A cell was used as a cell model to evaluate their biological effects.Cell viability and apoptosis assays were used to confirm the cytotoxicity induced by NaYF_4:Eu~(3+)NPs.Apart from the elevated malondialdehyde(MDA),the decrease of superoxide dismutase(SOD),glutathione peroxidase(GSH-PX)and catalase(CAT)activity indicated reactive oxygen species(ROS)generation,which were associated with oxidative damage.The decrease of mitochondrial membrane potential(MMP)value demonstrated the occurrence of mitochondria damage.Then,release of cytochrome c from mitochondria and activation of caspase-3 confirmed that NaYF_4:Eu~(3+)NPs induced apoptosis was mitochondria damage-dependent.     

Combined inhibition of HDAC and DNMT1 induces p85α/MEKmediated cell cycle arrest by dual target inhibitor 208 in U937 cells

Herein we reported an efficient dual DNMT and HDAC inhibitor 208 with great antiproliferative activity against U937 cells. Further studies revealed 208 affected the whole proteome profile and could induce G1 cell cycle arrest and apoptosis in U937 cells through upregulating CDK inhibitor p16 and downregulating cyclin-dependent kinases and their activators.     

Animal Lectins: Potential Antitumor Therapeutic Targets in Apoptosis

Lectins, a group of carbohydrate-binding proteins ubiquitously distributed into plants and animals, are well-known to have astonishing numerous links to human cancers. In this review, we present a brief outline of the representative animal lectins such as galectins, C-type lectins, and annexins by targeting programmed cell death (or apoptosis) pathways, and also summarize these representative lectins as possible anti-cancer drug targets. Taken together, these inspiring findings would provide a comprehensive perspective for further elucidating the multifaceted roles of animal lectins in apoptosis pathways of cancer, which, in turn, may ultimately help us to exploit lectins for their therapeutic purposes in future drug discovery.     

Macrophage colony-stimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-X(L)

Macrophage colony-stimulating factor (M-CSF) is known as one of the factors essential for osteoclast development. In the present study, we examined effects of M-CSF on the apoptotic pathway of osteoclast precursors and their underlying molecular mechanisms. Osteoclast precursors underwent apoptosis in the absence of M-CSF, even in the presence of receptor activator of NF-kappakB ligand (RANKL). Active caspase-3 and -9 were detected in the osteoclast precursors and treatments of precursors with their specific inhibitors (Z-DEVD-FMK and Z-LEHD-FMK) decreased the apoptosis. M-CSF decreased apoptosis in a dose-dependent manner with decreasing in active caspases-3 and -9 levels and up-regulating Bcl-X(L). Those effects of M-CSF on inhibiting apoptosis of osteoclasts precursor by regulating anti-apoptotic signals was more effective when combined with RANKL. These results demonstrate that M-CSF acts as a survival factor for the osteoclast precursors. Furthermore, it is believed that the apoptosis of osteoclast precursors may be involved in the activation of caspase-9 and that M-CSF may promote their survival through Bcl-X(L)-induced inhibition of caspase-9 activation.     

Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction

Elevated expression of inhibitor of apoptosis protein (IAP) family members in various types of cancers is thought to provide a survival advantage to these cells. Thus, antiapoptotic functions of IAPs, and their potential as novel anticancer targets have attracted considerable interest. Among the IAPs, the X chromosome-linked inhibitor of apoptosis protein (XIAP) is regarded as the most potent suppressor of mammalian apoptosis through direct binding and inhibition of caspases. A high-throughput biochemical screen of a combinatorial chemical library led to the discovery of a novel nonpeptidic small molecule that has the ability to disrupt the XIAP/caspase-3 interaction. The activity of this nonpeptidic small molecule inhibitor of the XIAP/caspase-3 interaction has been characterized both in vitro and in cells. Molecules of this type can be used to conditionally inhibit the cellular function of XIAP and may provide insights into the development of therapeutic agents that act by modulating apoptotic pathways.     

Apoptosis induced by NaYF<Subscript>4</Subscript>:Eu<Superscript>3+</Superscript> nanoparticles in liver cells via mitochondria damage dependent pathway

As lanthanide-doped sodium yttrium flouride (NaYF₄) nanoparticles have great potential in biomedical applications, their biosafety is important and has attracted significant attention. In the present work, three different sized NaYF₄:Eu³⁺ nanoparticles have been prepared. Liver BRL 3A cell was used as a cell model to evaluate their biological effects. Cell viability and apoptosis assays were used to confirm the cytotoxicity induced by NaYF₄:Eu³⁺ NPs. Apart from the elevated malondialdehyde (MDA), the decrease of superoxide dismutase (SOD), glutathione peroxidase (GSH-PX) and catalase (CAT) activity indicated reactive oxygen species (ROS) generation, which were associated with oxidative damage. The decrease of mitochondrial membrane potential (MMP) value demonstrated the occurrence of mitochondria damage. Then, release of cytochrome c from mitochondria and activation of caspase-3 confirmed that NaYF₄:Eu³⁺ NPs induced apoptosis was mitochondria damage-dependent.